Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

Abstract: The scaling of integrated circuits makes them more susceptible to faults, as the ones due to the effects of radiation and process variability. Failures related to process variability can ...

Already using NumPy, Pandas, and Scikit-learn? Here are seven more powerful data wrangling tools that deserve a place in your toolkit. Python’s rich ecosystem of data science tools is a big draw for ...

The Enhanced Reconsideration System (ERS) is a production-grade AI memory management library designed to transform stateless AI agents into stateful ones. It integrates asynchronous promise chains, ...

Officials estimate that pythons have killed 95% of small mammals as well as thousands of birds in Everglades National Park Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been ...

The Python Software Foundation warned users this week that threat actors are trying to steal their credentials in phishing attacks using a fake Python Package Index (PyPI) website. PyPI is a ...

Abstract: Nonlinear dynamical systems with oscillatory (periodic, quasi-periodic and chaotic) responses are analyzed in this paper through the method of Lyapunov exponents. The main goal is to present ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Five Jewish senators, including Democratic leader Chuck Schumer, have signed a letter accusing the Trump administration of using antisemitism as a “guise” to attack universities. The letter from the ...

Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...

^^^^^ File "/home/admin/.venv/lib/python3.12/site-packages/opentelemetry/instrumentation/urllib3/__init__.py", line 316, in instrumented_urlopen return wrapped(*args ...